Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.47 |
| ▸ | P2RY2 | P41231 | 16/20 | 0.42 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17732505 | 0.97 | P2RY2 (0.45) | FBP1P2RY2P2RY4P2RY6 | |
| SCHEMBL15745768 | 0.88 | FBP1 (0.62) | FBP1P2RY2P2RY6 | |
| SCHEMBL15293070 | 0.88 | FBP1 (0.62) | FBP1P2RY2P2RY6 | |
| SCHEMBL17789074 | 0.88 | FBP1 (0.62) | FBP1P2RY2P2RY6 | |
| SCHEMBL14945941 | 0.88 | FBP1 (0.62) | FBP1P2RY2P2RY6 | |
| SCHEMBL14928336 | 0.88 | FBP1 (0.62) | FBP1P2RY2P2RY6 | |
| SCHEMBL15745771 | 0.87 | FBP1 (0.46) | FBP1P2RY2P2RY4P2RY6 | |
| SCHEMBL15293069 | 0.87 | FBP1 (0.46) | FBP1P2RY2P2RY4P2RY6 | |
| SCHEMBL15745770 | 0.87 | FBP1 (0.46) | FBP1P2RY2P2RY4P2RY6 | |
| SCHEMBL14928841 | 0.87 | FBP1 (0.46) | FBP1P2RY2P2RY4P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140155473-A1 | MODIFIED GLUCOSIDASE, BETA, ACID POLYNUCLEOTIDES FOR TREATING PROTEIN DEFICIENCY | Moderna Threrapeutics, Inc. (US) | 2014-06-05 | — | — | US | disclosed |